Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance

BACKGROUND: Prostate cancer is the most common cancer in men and second leading cause of cancer-related deaths. Changes in screening guidelines, adoption of active surveillance (AS), and implementation of high-cost technologies have changed treatment costs. Traditional cost-effectiveness studies rel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol Open Sci
Main Authors: Magnani, Christopher J., Bievre, Nicolas, Baker, Laurence C., Brooks, James D., Blayney, Douglas W., Hernandez-Boussard, Tina
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Prostate Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751921/
https://ncbi.nlm.nih.gov/pubmed/33367287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euros.2020.11.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados